Indoco Remedies Limited
DSP Mutual Fund increased its stake in Indoco Remedies from 4.00% to 4.34% by increasing its shareholding from 3,695,939 to 4,008,147 shares. The value of the additional shares bought was approximately ₹7.72 crore at a share price of ₹247.45.
A Mumbai-based pharmaceutical company engaged in manufacturing and marketing finished dosage formulations and active pharmaceutical ingredients for domestic and international markets. Indoco Remedies operates across formulations, contract manufacturing, and research divisions, maintaining vertically integrated operations spanning drug development, manufacturing, and distribution. The company serves healthcare providers and patients through its diverse pharmaceutical portfolio and specialized manufacturing capabilities.
Standalone AMC after DSP Group acquired full ownership from BlackRock in 2018. Manages over Rs 1.9 lakh crore. Known for equity funds with a clear process-first culture and minimal star manager dependency. CEO Kalpen Parekh is widely respected for transparent investor communication. DSP Small Cap Fund and DSP Midcap Fund are flagship offerings.